H
AGN

Hexavest’s Allergan plc AGN Stock Holding History

Hexavest’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-104
Closed -$18K – 461
2020
Q1 		$18K Hold
104
– – ﹤0.01% 361
2019
Q4 		$20K Hold
104
– – ﹤0.01% 362
2019
Q3 		$18K Hold
104
– – ﹤0.01% 403
2019
Q2 		$17K Buy
+104
New +$14.4K ﹤0.01% 415

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Hexavest's AGN Position: Q2 2020 in Review

Hexavest sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 104 shares — an estimated $18K sold.

Hexavest first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $20K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Hexavest reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Hexavest sold 104 Allergan plc shares in Q2 2020, an estimated $18K.
  • Hexavest first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Hexavest's Allergan plc position peaked at $20K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Hexavest's 13F filing for Q2 2020, filed 10 Jul 2020.